𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells

✍ Scribed by Grant, Susan L; Hammacher, Annet; Douglas, Andrea M; Goss, Geraldine A; Mansfield, Rachel K; Heath, John K; Begley, C Glenn


Book ID
110066321
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
538 KB
Volume
21
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


EGF receptor (EGFR) signaling promoting
✍ Lorella Bonaccorsi; Vinicio Carloni; Monica Muratori; Lucia Formigli; Sandra Zec πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 975 KB

## Abstract We previously demonstrated that expression of androgen receptor (AR) by transfection of the androgen‐independent prostate cancer cell line PC3 decreases invasion and adhesion of these cells (PC3‐AR) through modulation of Ξ±6Ξ²4 integrin expression. The treatment with androgens further red

Estrogen-induced interaction between KLF
✍ Peng Guo; Xue-Yuan Dong; Ke-Wen Zhao; Xiaodong Sun; Qunna Li; Jin-Tang Dong πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 368 KB

## Abstract Kruppel‐like factor 5 (KLF5) is implicated in human breast cancer by frequent genomic deletion and expressional deregulation, but the molecular mechanisms by which KLF5 affects breast tumorigenesis are still unknown. This study was conducted to examine whether and how KLF5 affects the f

Bidirectional interactions between the e
✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/

Modulation of the estrogen-regulated pro
✍ Simone Panagiotou; Anastassia Hatzoglou; Fabien Calvo; Pierre-Marie Martin; Elia πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 273 KB πŸ‘ 3 views

In many cancer cell lines, including breast, prostate, lung, brain, head and neck, retina, and the gastrointestinal tract, opioids decrease cell proliferation in a dose-dependent and reversible manner. Opioid and/or other neuropeptide receptors mediate this decrease. We report that only the steroid-